The lasted report from WHO determined the increasing diversity within Omicron and its descendent lineages. Some offshoots of BA.5 and BA.2, such as BA.4.6, BF.7, BQ.1.1, and BA.2.75, were responsible for about 20% of infections and are spreading rapidly in multiple countries. It is a sign that Omicron subvariants are now developing a capacity to be more immune-escaping and may contribute to a new wave of COVID-19.

ACROBiosystems keep watching the development of SARS-CoV-2 and remain committed to contributing to the efforts against COVID-19. New variants of antigens, antibodies, and detection kits are successfully developed to support scientific research and vaccine, and therapeutic drug development!